Dr. Paul Barth Gilman, MD
- Medicare services, 2019
- 111
- Part D claims, 2024
- 24
- Publications
- 13
- Clinical trials
- 5
- Hospital affiliations
- 1
- Practice address
- 2010 W Chester Pike, Havertown, PA 19083
- Practice phone
- Call (610) 853-7700
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Christiana Care Havertown ASC, LLC
Havertown, Pennsylvania
Find Dr. Gilman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul Barth Gilman is a hematologist and oncologist in Havertown, Pennsylvania
Dr. Gilman practices at Christiana Care Havertown ASC, LLC in Havertown, Pennsylvania.
Dr. Gilman's NPI, 1215943634, was assigned on July 31, 2006. Dr. Gilman holds Pennsylvania license MD024195E.
- NPI
- 1215943634NPI Registry (opens in a new tab)
- NPI enumeration date
- July 31, 2006
- NPI status
- Active
- Practice phone
- (610) 853-7700
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Paul Barth Gilman practices at Christiana Care Havertown ASC, LLC in Havertown, Pennsylvania
Dr. Gilman's primary practice is Christiana Care Havertown ASC, LLC, at 2010 W Chester Pike, Havertown, PA 19083 in Delaware County. The practice phone is (610) 853-7700.
- Christiana Care Havertown ASC, LLC2010 W Chester Pike, Havertown, PA 19083 · Delaware CountyPhone(610) 853-7700
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Paul Barth Gilman is affiliated with 2 sites of care and 2 medical groups
Dr. Gilman's primary practice is Christiana Care Havertown ASC, LLC in Havertown, Pennsylvania. Dr. Gilman is also affiliated with Lankenau Medical Center. The medical group on file is Crozer Health Medical Group (CHMG). Dmand AI also links Dr. Gilman to 1 more medical group, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Paul Barth Gilman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Christiana Care Havertown ASC, LLC | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul Barth Gilman is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Gilman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gilman is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Gilman
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul Barth Gilman billed Medicare for 111 services in 2019
CMS data shows 111 Medicare services from Dr. Gilman across 3 procedure codes in 2019. Medicare paid $4,858 for them. Every service was in an office.
Dr. Gilman's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Office and hospital visits
- 2018: 6222019: 9585%
- Tests and treatments
- 2018: 4222019: 1696%
- Drugs given in the office
- 2018: 5,2202019: 0100%
- Surgery
- 2018: 462019: 0100%
Dr. Gilman compared with the Pennsylvania median for hematologists and oncologists, 2019
- Dr. Gilman
- Pennsylvania median
- Medicare services
- 111vs 65483% below
- Part D claims
- 12vs 39397% below
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Gilman's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gilman?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gilman and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paul Barth Gilman's patients have a median age of 57
Across all payers, Dmand AI patient panel data puts Dr. Gilman's median patient age at 57, with 57% women.
Dr. Gilman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 57
Patient panel by sex, all payers
- Women57%
- Men43%
Source: Dmand AI Patient Panel Data
Dr. Paul Barth Gilman wrote 24 Medicare Part D claims in 2024
In 2024, Dr. Gilman wrote 24 Medicare Part D claims. 79% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $5,228 in total drug cost. In 2022, CMS named 11 claims across 1 drug.
Dr. Gilman's Part D claims by kind of drug, 2024
- Generic19 claims79%
- Brand-name and other5 claims21%
Dr. Gilman's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 112023: 129%
Drugs named by CMS: 1 in 2023, 1 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul Barth Gilman has 13 publications on record
Dmand AI links 13 papers to Dr. Gilman, published from 2011 to 2022. 2013 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Breast Neoplasms. Dr. Gilman has published most often in Cancer. Dr. Gilman's most frequent co-authors are Rowan Chlebowski, MD, PhD, Julianne Hibbs, DO and Virginia G. Kaklamani, MD.
Dr. Gilman's papers by year, 2011 to 2022
Topics Dr. Gilman writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
Dr. Gilman's most frequent co-authors
- Rowan Chlebowski, MD, PhD2 shared papers
- Julianne Hibbs, DO2 shared papers
- Virginia G. Kaklamani, MD2 shared papers
Recent publications by Dr. Gilman
See who Dr. Gilman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Gilman works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul Barth Gilman has worked on 5 clinical trials
Dmand AI links Dr. Gilman to 5 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Non-Small-Cell Lung. Open Payments lists research payments to Dr. Gilman that name 1 trial.
Clinical trials with Dr. Gilman by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Gilman's trials
- Breast Neoplasms
- Breast Diseases
- Carcinoma, Non-Small-Cell Lung
- Uterine Cervical Neoplasms
- Carcinoma, Bronchogenic
Investigators on the most trials with Dr. Gilman
- Manuel Borrego, MD2 shared trials
- Raymond Brig, MD2 shared trials
- Jay Gordon Courtright, MD2 shared trials
Recent clinical trials with Dr. Gilman
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer (opens in a new tab)
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy (opens in a new tab)
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paul Barth Gilman received $11,653 in industry payments from 2016 to 2022
CMS Open Payments shows 352 general payments to Dr. Gilman from 34 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 56% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $5,267. It also lists 1 research payment totaling $2,758 in 2024, naming 1 clinical trial.
General payments to Dr. Gilman by program year, 2016 to 2022
General payments to Dr. Gilman by kind, 2016 to 2022
- Food and beverage$6,56956%
- Speaker and faculty fees$4,46338%
- Consulting fees$4344%
- Education$1591%
- Travel and lodging$280%
Companies that paid Dr. Gilman the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Paul Barth Gilman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul Barth Gilman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul Barth Gilman's NPI number?
Dr. Paul Barth Gilman's NPI number is 1215943634. It was assigned on July 31, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul Barth Gilman?
Dr. Paul Barth Gilman is a hematologist and oncologist in Havertown, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Paul Barth Gilman practice?
Dr. Gilman practices at 2010 W Chester Pike, Havertown, PA 19083. Dr. Gilman's primary practice is Christiana Care Havertown ASC, LLC in Havertown, Pennsylvania. Dmand AI also links Dr. Gilman to 1 medical group.
What is Dr. Paul Barth Gilman's office phone number?
The practice phone on file for Dr. Gilman is (610) 853-7700.
What is Dr. Paul Barth Gilman's medical license number?
Dr. Gilman holds Pennsylvania license MD024195E.
Which hospitals is Dr. Paul Barth Gilman affiliated with?
Dr. Gilman is affiliated with Lankenau Medical Center.
What medical group is Dr. Paul Barth Gilman part of?
Dr. Gilman is linked to Crozer Health Medical Group (CHMG). Dmand AI links Dr. Gilman to 1 more medical group.
Does Dr. Paul Barth Gilman accept Medicare?
Yes. CMS data shows Dr. Gilman billed Medicare for 111 services in 2019.
What services does Dr. Paul Barth Gilman bill to Medicare?
In 2019, Dr. Gilman's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and infusion or chemotherapy administration (96372).
What drugs does Dr. Paul Barth Gilman prescribe most?
In 2023 Medicare Part D data, Dr. Gilman's most prescribed drugs by claims were Breo Ellipta.
Show 4 more questionsShow fewer questions
Has Dr. Paul Barth Gilman received payments from drug or device companies?
CMS Open Payments shows $11,653 in general payments to Dr. Gilman from 34 companies from 2016 to 2022. The largest total came from Boehringer Ingelheim Pharmaceuticals, Inc.
How long has Dr. Paul Barth Gilman been practicing?
Dr. Gilman's NPI was assigned in 2006.
Does Dr. Paul Barth Gilman do research?
Dmand AI links 13 publications to Dr. Gilman, published from 2011 to 2022. Dr. Gilman has worked on 5 clinical trials.
Who does Dr. Paul Barth Gilman publish with?
Dr. Gilman's most frequent co-authors are Rowan Chlebowski, MD, PhD (2 shared papers), Julianne Hibbs, DO (2 shared papers) and Virginia G. Kaklamani, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card